Intramyocellular Triglyceride Content During the Early Course of Type 1 and Type 2 Diabetes
Overview
Authors
Affiliations
Article Highlights: Intramyocellular lipid content (IMCL) can be elevated in insulin-resistant humans, but its dynamics and association with comorbidities remain unclear. Independently of age, sex, body mass, and skeletal muscle volume, IMCL is higher in recent-onset type 2, but not type 1 diabetes, and remains unchanged within 5 years, despite worsening insulin resistance. A degree of physical fitness modulates the association between IMCL and insulin sensitivity in type 2 diabetes. Whereas higher IMCL associates with lower insulin sensitivity in people with lower physical fitness, there is no association between IMCL and insulin sensitivity in those with higher degree of physical fitness. IMCL associates with progression of microalbuminuria, cardiovascular disease risk, and cardiac autonomic neuropathy.
Alterations of hepatic lipid content following COVID-19 in persons with type 2 diabetes.
Kupriyanova Y, Yurchenko I, Bobrov P, Bartels F, Wierichs S, Jonuscheit M BMJ Open Diabetes Res Care. 2025; 13(1).
PMID: 39965871 PMC: 11836859. DOI: 10.1136/bmjdrc-2024-004727.